🔗 Permalink

Inventor profile of:

Manfred SCHMITT

City:

Münich

Country:

Germany

Published Applications:

Last publication date:

2019-10-24

Top Assignees for applications by Manfred SCHMITT

The entities that hold a legal rights for patent applications filed by inventor SCHMITT Manfred:

Epigenomics AG 4 Berlin, Germany
Wilex AG 2 Munich, Germany
WILEX AG 1 Muenchen, Germany
THERAWIS DIAGNOSTICS GMBH 1 München, Germany
Wilex AG 1 München, Germany
SYSMEX CORPORATION 1 Kobe-shi,, Japan
THERAWIS DIAGNOSTICS GMBH 1 Munich, Germany
SYSMEX CORPORATION 1 Hyogo, Japan

Recent patent applications by SCHMITT Manfred

Manfred SCHMITT from Münich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-10-24

US20190323084A1

Chemistry; metallurgy

Methods for assessing the treatment response of TNBC patients to neo-adjuvant chemotherapy by analysing CpG methylation

#2 | 2019-08-01

US20190233899A1

Chemistry; metallurgy

METHODS FOR SELECTING TREATMENT REGIMENS AND PREDICTING OUTCOMES IN CANCER PATIENTS

#3 | 2018-10-04

US20180282822A1

Chemistry; metallurgy

METHODS FOR SELECTING TREATMENT REGIMENS AND PREDICTING OUTCOMES IN CANCER PATIENTS

#4 | 2013-12-05

US20130323748A1

Physics

Method of judging risk of cancer recurrence and computer program

#5 | 2012-07-19

US20120184455A1

Chemistry; metallurgy

Method and Nucleic Acids for the Improved Treatment of Breast Cell Proliferative Disorders

#6 | 2009-08-13

US20090202504A1

Chemistry; metallurgy

Nucleic acids encoding a deletion variant of uPAR

#7 | 2009-04-30

US20090111707A1

Chemistry; metallurgy

Markers for the prediction of outcome of anthracycline treatment

#8 | 2008-10-16

US20080254447A1

Chemistry; metallurgy

Methods for the prognosis of breast cancer

#9 | 2007-03-22

US20070066798A1

Chemistry; metallurgy

Diagnostic and therapeutic use of antibodies against the urokinase receptor

#10 | 2006-06-08

US20060121467A1

Chemistry; metallurgy

Method for determining risk of relapse of breast cancer following tamoxifen adjuvant therapy

#11 | 2006-04-20

US20060084056A1

Chemistry; metallurgy

Methods for selecting treatment regimens and predicting outcomes in cancer patients

#12 | 2006-02-02

US20060024684A1

Chemistry; metallurgy

Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients

InventorID:

2312018 ⎘